Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Public offering brings in $24.9mm for PolarityTE

Executive Summary

PolarityTE Inc. netted $24.9mm through a public offering of 2.97mm common shares at $8.51. The company is developing technology to use a patient's own cells and tissues to regenerate functionally-polarized human tissue, and will use the offering proceeds to support R&D, manufacturing, regulatory, and future commercialization of its projects.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies